Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Medioni

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
BJU International|February 13, 2009
What is the real impact of bone pain on survival in patients with metastatic hormone-refractory prostate cancer treated with docetaxel?Stéphane Oudard, Eugeniu Banu, Jacques Medioni, et al.
Oncology|June 26, 2013
Rechallenge with mTOR inhibitors in metastatic renal cell carcinoma patients who progressed on previous mTOR inhibitor therapyAgnes Maj-Hes, Jacques Medioni, Florian Scotte, et al.
Clinical Breast Cancer|November 14, 2022
Benefits of Homeopathic Complementary Treatment in Patients With Breast Cancer: A Retrospective Cohort Study Based on the French Nationwide Healthcare DatabaseJacques Medioni, Daniel Scimeca, Yecenia Lopez Marquez, et al.
Critical Reviews in Oncology/Hematology|May 29, 2019
Vinflunine in the treatment of relapsed metastatic urothelial cancer: A systematic review and meta-analysis of real-world seriesAristotelis Bamias, Axel Hegele, Jacques Medioni, et al.
Therapie|June 21, 2022
Pulmonary toxicity of mTOR inhibitors. Comparisons of two populations: Solid organ recipients and cancer patientsSébastien Gendarme, Jean Pastré, Eliane M Billaud, et al.
European Urology|January 23, 2009
Salvage therapy with bevacizumab-sunitinib combination after failure of sunitinib alone for metastatic renal cell carcinoma: a case seriesJacques Medioni, Eugeniu Banu, Dominique Helley, et al.
The International Journal of Biological Markers|May 1, 2009
Quantification of VEGF isoforms and VEGFR transcripts by qRT-PCR and their significance in acute myeloid leukemiaSamia Mourah, Raphael Porcher, Géraldine Lescaille, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 1, 2013
Ovarian cancer: sites of recurrencePascale Amate, Cyrille Huchon, Anne Lucie Dessapt, et al.
Bulletin Du Cancer|June 17, 2019
[Drug management of cancer-related peripheral neuropathic pain: A systematic review of the literature]Jacques Medioni, Gisèle Pickering, Claire Delorme, et al.
Cancer|February 21, 2008
Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the footFlorian Scotté, Eugeniu Banu, Jacques Medioni, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
BJU International|February 13, 2009
What is the real impact of bone pain on survival in patients with metastatic hormone-refractory prostate cancer treated with docetaxel?Stéphane Oudard, Eugeniu Banu, Jacques Medioni, et al.
Oncology|June 26, 2013
Rechallenge with mTOR inhibitors in metastatic renal cell carcinoma patients who progressed on previous mTOR inhibitor therapyAgnes Maj-Hes, Jacques Medioni, Florian Scotte, et al.
Clinical Breast Cancer|November 14, 2022
Benefits of Homeopathic Complementary Treatment in Patients With Breast Cancer: A Retrospective Cohort Study Based on the French Nationwide Healthcare DatabaseJacques Medioni, Daniel Scimeca, Yecenia Lopez Marquez, et al.
Critical Reviews in Oncology/Hematology|May 29, 2019
Vinflunine in the treatment of relapsed metastatic urothelial cancer: A systematic review and meta-analysis of real-world seriesAristotelis Bamias, Axel Hegele, Jacques Medioni, et al.
Therapie|June 21, 2022
Pulmonary toxicity of mTOR inhibitors. Comparisons of two populations: Solid organ recipients and cancer patientsSébastien Gendarme, Jean Pastré, Eliane M Billaud, et al.
European Urology|January 23, 2009
Salvage therapy with bevacizumab-sunitinib combination after failure of sunitinib alone for metastatic renal cell carcinoma: a case seriesJacques Medioni, Eugeniu Banu, Dominique Helley, et al.
The International Journal of Biological Markers|May 1, 2009
Quantification of VEGF isoforms and VEGFR transcripts by qRT-PCR and their significance in acute myeloid leukemiaSamia Mourah, Raphael Porcher, Géraldine Lescaille, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 1, 2013
Ovarian cancer: sites of recurrencePascale Amate, Cyrille Huchon, Anne Lucie Dessapt, et al.
Bulletin Du Cancer|June 17, 2019
[Drug management of cancer-related peripheral neuropathic pain: A systematic review of the literature]Jacques Medioni, Gisèle Pickering, Claire Delorme, et al.
Cancer|February 21, 2008
Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the footFlorian Scotté, Eugeniu Banu, Jacques Medioni, et al.
Pageof 6